OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apitoxin and Its Components against Cancer, Neurodegeneration and Rheumatoid Arthritis: Limitations and Possibilities
Andreas Aufschnaiter, Verena Kohler, Shaden Khalifa, et al.
Toxins (2020) Vol. 12, Iss. 2, pp. 66-66
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Honey Bee Products: Preclinical and Clinical Studies of Their Anti-inflammatory and Immunomodulatory Properties
Hesham R. El‐Seedi, Nehal Eid, Aida A. Abd El‐Wahed, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 87

Antimicrobial Activity of Bee-Collected Pollen and Beebread: State of the Art and Future Perspectives
Nikos Asoutis Didaras, Katerina Karatasou, Tilemachos G. Dimitriou, et al.
Antibiotics (2020) Vol. 9, Iss. 11, pp. 811-811
Open Access | Times Cited: 95

Bee Venom: From Venom to Drug
Abdelwahab Khalil, Basem H. Elesawy, Tarek M. Ali, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4941-4941
Open Access | Times Cited: 66

Bee Pollen: Clinical Trials and Patent Applications
Jari S. Algethami, Aida A. Abd El‐Wahed, Mohamed H. Elashal, et al.
Nutrients (2022) Vol. 14, Iss. 14, pp. 2858-2858
Open Access | Times Cited: 48

Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective
Peiying Shi, Shihui Xie, Jiali Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41

An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
Pratibha Pandey, Fahad Khan, Minhaj Ahmad Khan, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3111-3111
Open Access | Times Cited: 39

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies
Xiang Yu, Siyu Jia, Yu Shi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 24

Therapeutic Effects of Apamin as a Bee Venom Component for Non-Neoplastic Disease
Hyemin Gu, Sang‐Mi Han, Kwan‐Kyu Park
Toxins (2020) Vol. 12, Iss. 3, pp. 195-195
Open Access | Times Cited: 58

Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells
Ghada H. Mansour, Mohammed A. El‐Magd, Dalia H. Mahfouz, et al.
Bioorganic Chemistry (2021) Vol. 116, pp. 105329-105329
Closed Access | Times Cited: 42

Pharmacological properties and therapeutic potential of honey bee venom
Amjad Ullah, Fahad M. Aldakheel, Syed Ishtiaq Anjum, et al.
Saudi Pharmaceutical Journal (2022) Vol. 31, Iss. 1, pp. 96-109
Open Access | Times Cited: 31

Chemical Profiling and Nutritional Evaluation of Bee Pollen, Bee Bread, and Royal Jelly and Their Role in Functional Fermented Dairy Products
Amira M.G. Darwish, Aida A. Abd El‐Wahed, Mohamed G. Shehata, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 227-227
Open Access | Times Cited: 29

Chemical Composition and Antimicrobial Properties of Honey Bee Venom
Valery A. Isidorov, Adam Zalewski, Grzegorz Zambrowski, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4135-4135
Open Access | Times Cited: 16

Immunomodulatory activities and biomedical applications of melittin and its recent advances
Zohreh Jafari, Sahar Sadeghi, Mahsa Mirzarazi Dehaghi, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 7

Targeted delivery of bee venom to A549 lung cancer cells by PEGylate liposomal formulation: an apoptotic investigation
Samireh Badivi, Sara Kazemi, Mohammadmahdi Eskandarisani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7

Bee chitosan nanoparticles loaded with apitoxin as a novel approach to eradication of common human bacterial, fungal pathogens and treating cancer
Mohamed H. Sharaf, Abdullah A. Zahra, Maha Alharbi, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6

Effectual Anticancer Potentiality of Loaded Bee Venom onto Fungal Chitosan Nanoparticles
Adel I. Alalawy, Haddad A. El Rabey, Fahad M. Almutairi, et al.
International Journal of Polymer Science (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 47

Potentiality of Melittin-Loaded Niosomal Vesicles Against Vancomycin-Intermediate Staphylococcus aureus and Staphylococcal Skin Infection
Sirikwan Sangboonruang, Natthawat Semakul, Mohammad A. Obeid, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7639-7661
Open Access | Times Cited: 34

Fabrication and characterization of bee venom-loaded nanoliposomes: Enhanced anticancer activity against different human cancer cell lines via the modulation of apoptosis-related genes
Alaa Abd El-Gawad, Mohamed Kenawy, Tamer M. El‐Messery, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 84, pp. 104545-104545
Closed Access | Times Cited: 15

Why to Study Peptides from Venomous and Poisonous Animals?
Ana Oliveira, Andreimar M. Soares, Saulo L. da Silva
International Journal of Peptide Research and Therapeutics (2023) Vol. 29, Iss. 5
Open Access | Times Cited: 13

Melittin: A Promising Therapeutic Agent for Rheumatoid Arthritis Treatment
Rong Huang, Xiying He, Qingxin Meng, et al.
Toxicon (2025), pp. 108335-108335
Closed Access

Royal Jelly: Beneficial Properties and Synergistic Effects with Chemotherapeutic Drugs with Particular Emphasis in Anticancer Strategies
Suzy Munir Salama, Qiyang Shou, Aida A. Abd El‐Wahed, et al.
Nutrients (2022) Vol. 14, Iss. 19, pp. 4166-4166
Open Access | Times Cited: 21

Natural product extract fractions as potential arthritis treatments: A detailed analysis using in-silico, in-vivo, and in-vitro methods
Bharathiraja Anthony Samy, Kannan Raman, Suresh Velayutham, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113595-113595
Open Access | Times Cited: 4

Suppression of skin lesions and SLE nephritis by increasing Treg in MRL/FASlpr mice by administration of Bee venom Apitoxin®
Duk-Yeon Cho, Young Mo Kang, Sang-Ho Seol
Research Square (Research Square) (2025)
Closed Access

Page 1 - Next Page

Scroll to top